Literature DB >> 34309793

Incidence and risk factors for postoperative intraocular pressure response to topical prednisolone eye drops in patients undergoing phacoemulsification.

Sharmila Rajendrababu1, Srilekha Pallamparthy2, Anusha Arunachalam2, Mohammed Sithiq Uduman3, Senthilkumari Srinivasan4, S R Krishnadas2, Vijayalakshmi A Senthilkumar2.   

Abstract

AIM/
PURPOSE: To report the incidence, risk factors, and magnitude of steroid response in individuals receiving topical 1% prednisolone acetate eye drops following phacoemulsification surgery
MATERIALS AND METHODS: Postoperative IOP of 1118 consecutive patients who had uneventful cataract surgery and used 1% topical prednisolone acetate were studied. Baseline ocular parameters like best-corrected visual acuity, IOP, and slit-lamp examination findings were noted preoperatively and at postoperative day 30. Incidence of postoperative intraocular pressure response to steroid was analyzed and graded as mild, moderate, or severe and risk factors studied.
RESULTS: The mean age of our study cohort was 59.49 ± 7.25 years. The overall incidence of steroid response was 3.2%, (2.8% being moderate responders, and 0.4% high responders). Mean preoperative IOP was 14.67 ± 2.2 mm Hg in the study cohort (n = 1118). Mean postoperative IOP was 21.33 ± 7.97 mm Hg in the steroid responder (SR) and 14.66 ± 2.8 mm Hg in the non-responder (NR), with a statistically significant difference from the baseline IOP in the SR group (p < 0.001) and no difference in the NR. Univariate analysis revealed younger age and high axial length as risk factors but on multiple regression analysis, only younger age < 50 years was found to be a significant risk factor for steroid response.
CONCLUSION: The overall steroid response in this population post-cataract surgery was low with most being moderate responders. Younger age and higher axial length were identified as risk factors for steroid response, and hence this warrants the judicious use of steroids in such individuals.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Post-cataract IOP response; Risk factors; Steroid responders and non-responders; Steroid response; Transient IOP spike; Treatment options

Mesh:

Substances:

Year:  2021        PMID: 34309793     DOI: 10.1007/s10792-021-01972-1

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  26 in total

1.  EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. II. THE EFFECT OF DEXAMETHASONE IN THE GLAUCOMATOUS EYE.

Authors:  M F ARMALY
Journal:  Arch Ophthalmol       Date:  1963-10

2.  CORTICOSTEROIDS AND INTRAOCULAR PRESSURE.

Authors:  B BECKER; D W MILLS
Journal:  Arch Ophthalmol       Date:  1963-10

3.  TOPICAL CORTICOSTEROIDS AND HEREDITY IN PRIMARY OPEN-ANGLE GLAUCOMA.

Authors:  B BECKER; K A HAHN
Journal:  Am J Ophthalmol       Date:  1964-04       Impact factor: 5.258

4.  STATISTICAL ATTRIBUTES OF THE STEROID HYPERTENSIVE RESPONSE IN THE CLINICALLY NORMAL EYE. I. THE DEMONSTRATION OF THREE LEVELS OF RESPONSE.

Authors:  M F ARMALY
Journal:  Invest Ophthalmol       Date:  1965-04

5.  Intraocular pressure response to topical corticosteroids.

Authors:  M F Armaly; B Becker
Journal:  Fed Proc       Date:  1965 Nov-Dec

6.  A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery.

Authors:  Eric D Donnenfeld; Edward J Holland; Kerry D Solomon; Jay Fiore; Anthony Gobbo; Jessica Prince; Helga P Sandoval; Emily R Shull; Henry D Perry
Journal:  Am J Ophthalmol       Date:  2011-06-25       Impact factor: 5.258

Review 7.  Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management.

Authors:  Gloria Roberti; Francesco Oddone; Luca Agnifili; Andreas Katsanos; Manuele Michelessi; Leonardo Mastropasqua; Luciano Quaranta; Ivano Riva; Lucia Tanga; Gianluca Manni
Journal:  Surv Ophthalmol       Date:  2020-02-11       Impact factor: 6.048

8.  Risk factors for steroid response among cataract patients.

Authors:  David F Chang; Jeffrey J Tan; Yorghos Tripodis
Journal:  J Cataract Refract Surg       Date:  2011-04       Impact factor: 3.351

Review 9.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

10.  Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma.

Authors:  Wayne R Lo; Laura Leigh Rowlette; Montserrat Caballero; Ping Yang; M Rosario Hernandez; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.